What Happens When You Stop Taking a GLP-1

Educational content, reviewed for accuracy against published clinical literature. Not medical advice.

One of the most important things to understand about GLP-1 medications is what can happen when you stop taking them. This is not meant to discourage you, but to help you make informed decisions about your treatment.

What Research Shows

Studies have consistently found significant weight regain after stopping GLP-1 medications:

STEP 1 Extension Trial (Semaglutide):

• Participants lost an average of 17% of body weight during treatment
• After stopping, they regained approximately two-thirds of the lost weight within one year
• Cardiometabolic improvements (blood pressure, cholesterol, etc.) also partially reversed

SURMOUNT-4 Trial (Tirzepatide):

• 82.5% of participants who stopped regained at least 25% of their lost weight within one year
• Those who continued medication maintained their weight loss

Broader reviews of the research find:

• Weight regain typically begins within about two months of stopping
• Regain then continues gradually over the following year or more, though the pace varies from person to person

Why This Happens?

Weight regain after stopping is not failure or lack of willpower. It is biology:

Hormonal changes persist: Leptin remains low and ghrelin remains high after weight loss. When medication stops, you feel these effects fully.

Appetite returns: The appetite suppression and reduced food noise provided by the medication disappear. Many people describe hunger returning powerfully.

Metabolic adaptation: Your metabolism has adjusted to your lower weight. Without medication helping manage appetite, eating at maintenance becomes very difficult.

The underlying condition remains: Obesity involves complex biological factors. Stopping medication does not “cure” these factors.

What This Means

For most people, GLP-1 medications work best as long-term or ongoing treatment, similar to:

• Blood pressure medication for hypertension
• Statins for cholesterol
• Antidepressants for depression

Stopping medication is always an option, but should be done with realistic expectations and your provider’s guidance.

If You Are Considering Stopping

Reasons people consider stopping include cost, side effects, reaching goal weight, or personal preference. If you are thinking about it:

• Discuss with your provider first
• Understand the likely outcomes
• Have a plan for monitoring and responding to changes/li>
• Know that restarting is usually an option

How Blum Helps

• Injection log and weight trends give you a complete treatment history in one place
• Lifestyle Mode helps you hold onto your habits and your results if treatment ends
• Provider Report Export supports informed conversations about long-term treatment planning
• Weight trends provide context for maintenance decisions instead of day-to-day panic

Key Takeaways

• Research shows most people regain significant weight after stopping
• STEP 1 found two-thirds of weight regained within one year
• This happens because of persistent hormonal changes, not willpower failure
• Most people benefit from long-term treatment
• Stopping should be discussed with your provider with realistic expectations
• Talk to your healthcare provider if you are considering stopping medication for any reason, or you want to discuss long-term treatment planning.
• This is general educational information. Please discuss your specific situation with your healthcare provider.

Sources

1. Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9542252/
2. Aronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024. https://pubmed.ncbi.nlm.nih.gov/38078870/
3. Horn DB et al. Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal: A Post Hoc Analysis of the SURMOUNT-4 Trial. JAMA Intern Med 2025. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2841273

Related Articles

• Metabolic Adaptation: Why Your Body Fights Weight Loss
• GLP-1 Weight Loss Timeline: What to Expect Month by Month
• Switching GLP-1 Medications: What the Transition Involves

This article is general educational information about GLP-1 medications and is not medical advice. It does not replace guidance from your prescriber or pharmacist. Always follow your healthcare provider’s instructions, and contact them about any symptom that is severe, persistent, or concerning.